-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Omada Health, Lowers Price Target to $22

Benzinga·03/06/2026 19:27:15
Listen to the news
Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and lowers the price target from $28 to $22.